SBIR/STTR Research Award
A Novel Biological Therapy (PC-01) for Ocular Surface Regeneration
Award amount
$149,967Program and phase
STTR · Phase IAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- OCUBIO, LLC
- Proposal award date
- 2021-01-14
- Contract end date
- 2021-07-15
- UEI
- GKSDH7WKL834
- Solicitation number
- X20.D
- Topic code
- AFX20D-TCSO1
Research abstract
Human performance and endurance during military deployments will rely on the health or rapid recovery in case of eye damage. In the military, pilots can suffer from dry eye due to extreme drought condition during long mission. Other USAF personnel can exp
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Extremely Lightweight and Ultra-Low Noise Isolated DC-DC Converters
- Continuous Fiber Additive Manufacturing for Rapid Prototyping and Demonstration of Small UAS Designs
- Deployable Containerized LH2 Refueling System
- Extremely Lightweight and Ultra-Low Noise Isolated DC-DC Converters
- Advanced Li-Metal, High-Power Battery
Research funding history
2 SBIR/STTR records share this UEI (2021–2022). Reported award amounts total $899,855. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Defense